No abstract available
MeSH terms
-
Adult
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Agents / pharmacology
-
Antineoplastic Agents / therapeutic use*
-
Combined Modality Therapy
-
Crohn Disease / complications*
-
Crohn Disease / drug therapy
-
Female
-
Follow-Up Studies
-
Humans
-
Immunocompromised Host
-
Immunosuppressive Agents / adverse effects
-
Immunosuppressive Agents / therapeutic use
-
Interferon alpha-2
-
Interferon-alpha / administration & dosage
-
Interferon-alpha / pharmacology
-
Interferon-alpha / therapeutic use*
-
Melanoma / complications
-
Melanoma / drug therapy*
-
Melanoma / surgery
-
Recombinant Proteins / administration & dosage
-
Recombinant Proteins / pharmacology
-
Recombinant Proteins / therapeutic use
-
Remission Induction
-
Skin Neoplasms / complications
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / surgery
Substances
-
Antineoplastic Agents
-
Immunosuppressive Agents
-
Interferon alpha-2
-
Interferon-alpha
-
Recombinant Proteins